CASE STUDY: EVOLUTION IN THE MEDICAL DEVICE SUPPLY CHAIN Cardinal Health and DHL discuss trust and partnership in logistics and back office
With
Steve Thompsett, CEO
DHL Supply Chain Australia and New Zealand
Michael Gardner,
(Former) VP Life Sciences & Healthcare
DHL Supply Chain Australia
Shane McCormack,
Senior Manager Supply Chain
Cardinal Health
Australian Health Journal segment
Filmed in Sydney | April 2025
Supply chain and logistics involve managing products globally, from manufacturing to distribution. This includes international shipping via air and sea, storing products in temperature-controlled warehouses, and delivering them to pharmacies, medical wholesalers, and hospitals within the domestic market.
Michael Gardner, (Former) VP Life Sciences & Healthcare, DHL Supply Chain Australia spoke to Australian Health Journal about the medical device industry being particularly complex; onboarding a new customer at DHL supply chain demands thorough preparation. This process involves understanding the customer’s operations and the lifecycle of their products, from their arrival at the warehouse to their use in patient care. Insight into the customer’s expectations is crucial to ensure seamless operations.
For Cardinal Health, a global manufacturer and distributor of medical products, the process begins when products arrive in Australia and are cleared by customs before being stored at their Sydney warehouse. From here, they fulfil orders for various clients, including hospitals and wholesalers, supported by DHL’s logistics services.
In this case study, Australian Health Journal was given the opportunity to talk to both the logistics provider and the end medical technology client in what is an evolving medical device supply chain.
Challenges in Australia include a limited manufacturing workforce and the distances to raw material sources, with all imported products being finished goods. Compliance with safety and regulatory standards is essential. In addition to logistics, DHL provides value-added services like equipment repairs and a 4PL service, which includes customer service support and accounts receivable, enhancing efficiency for Cardinal Health.
Credit: MedTech24 Conference, hosted by Medical Technology Association of Australia (MTAA) in Sydney, October 2024.
Source: Written by AUDIENCED, with use of generative AI on transcript
-
The desire for primary care nurses to do more, be recognised and valued for the work they do
Denise Lyons is a highly experienced nurse with over 40 years in the profession, including more than 25 years dedicated to primary care. She earned her Bachelor of Science in Nursing in the United States in 1985 and, in 2012, became an endorsed Nurse Practitioner in Australia. Currently, she serves as a primary care Nurse Practitioner in General Practice in Newcastle, where she is committed to delivering high-quality, patient-centred care that improves the health and wellbeing of her community.
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
-
Maximising benefits, minimising harms in population health screening
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
